RL23 Statistical Issus in Pharmacogenetics
*Liling Warren, GalxoSmithKline Keywords: Pharmacogenetics holds promises to deliver better and safer medicines to patients, yet it is posing many practical and statistical challenges to become an integral part of the drug development process. From drug discovery, preclinical development, through phases of clinical trials, to post-marketing studies, different statistical issues arise when combing genetic data with patient demographic, drug safety and efficacy data. How to define analysis populations? What’s the most appropriate statistical method? How to evaluate clinical utility of the findings? How to validate interesting results prospectively? At this roundtable, we will discuss these issues, share experiences and brainstorm on how to effectively apply genetics to drug development with the goal to develop the right medicines at the right dose for the right patients.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC